Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was deleted, reflecting an updated version tag for the record rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-05-18T04:00:21.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from **v3.5.0** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:27:00.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma to the list of conditions and updated the study version from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T17:20:11.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:58:00.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' under Conditions and introduced a new Resources link to the Genetic and Rare Diseases Information Center. Removed the older Revision: v3.4.1 entry.
    Difference
    0.2%
    Check dated 2026-02-14T02:00:44.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    The revision label updated from v3.4.0 to v3.4.1. This appears to be a version update with no impact on the study details or page content.
    Difference
    0.0%
    Check dated 2026-02-06T17:42:09.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.